PCA3 gene expression levels were shown to be an important tool in augmenting serum PSA testing, particularly in cases when raised PSA levels were due to prostatitis rather than to cancer on initial biopsy, in men under surveillance with Gleason score 6 and less, and in men with prostate cancer and normal PSA levels [38]. The gene discussed is KLK3; the disease is prostate carcinoma.